These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37231148)

  • 1. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.
    Bao YF; Li XY; Dong Y; Wu ZY
    J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
    da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
    J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range.
    Findlay Black H; Wright GEB; Collins JA; Caron N; Kay C; Xia Q; Arning L; Bijlsma EK; Squitieri F; Nguyen HP; Hayden MR
    Genet Med; 2020 Dec; 22(12):2108-2113. PubMed ID: 32741964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
    Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
    Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.
    Choi DE; Shin JW; Zeng S; Hong EP; Jang JH; Loupe JM; Wheeler VC; Stutzman HE; Kleinstiver B; Lee JM
    Elife; 2024 Jun; 12():. PubMed ID: 38869243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
    Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
    Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene.
    Liu ZJ; Sun YM; Ni W; Dong Y; Shi SS; Wu ZY
    Clin Genet; 2014 Feb; 85(2):189-93. PubMed ID: 23398026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohort.
    Dawson J; Kay C; Black HF; Bortnick S; Javier K; Xia Q; Sandhu A; Buchanan C; Hogg V; Chang FCF; Goto J; Arning L; Saft C; Bijlsma EK; Nguyen HP; Roxburgh R; Hayden MR
    Genet Med; 2024 Nov; 26(11):101239. PubMed ID: 39140258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
    Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
    Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.
    Murmann AE; Patel M; Jeong SY; Bartom ET; Jennifer Morton A; Peter ME
    Cell Death Dis; 2022 Dec; 13(12):1078. PubMed ID: 36585400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
    Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
    EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation.
    Ciosi M; Cumming SA; Chatzi A; Larson E; Tottey W; Lomeikaite V; Hamilton G; Wheeler VC; Pinto RM; Kwak S; Morton AJ; Monckton DG
    J Huntingtons Dis; 2021; 10(1):53-74. PubMed ID: 33579864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.
    Aldous SG; Smith EJ; Landles C; Osborne GF; Cañibano-Pico M; Nita IM; Phillips J; Zhang Y; Jin B; Hirst MB; Benn CL; Bond BC; Edelmann W; Greene JR; Bates GP
    Brain; 2024 May; 147(5):1784-1798. PubMed ID: 38387080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.
    Ahmad M; Ríos-Anillo MR; Acosta-López JE; Cervantes-Henríquez ML; Martínez-Banfi M; Pineda-Alhucema W; Puentes-Rozo P; Sánchez-Barros C; Pinzón A; Patel HR; Vélez JI; Villarreal-Camacho JL; Pineda DA; Arcos-Burgos M; Sánchez-Rojas M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
    De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.